RETINOPATHY OF PREMATURITY (ROP)

Clinical trials for RETINOPATHY OF PREMATURITY (ROP) explained in plain language.

Never miss a new study

Get alerted when new RETINOPATHY OF PREMATURITY (ROP) trials appear

Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY (ROP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 2

New hope for tiniest babies: experimental drug aims to prevent devastating lung disease

Prevention Recruiting now

This study is testing whether an investigational drug called OHB-607 can prevent a serious lung condition called bronchopulmonary dysplasia (BPD) in extremely premature infants. It will compare the drug to standard neonatal care alone in about 338 babies born between 23 and 28 we…

Matched conditions: RETINOPATHY OF PREMATURITY (ROP)

Phase: PHASE2 • Sponsor: OHB Neonatology Ltd. • Aim: Prevention

Last updated Mar 19, 2026 14:56 UTC

RETINOPATHY OF PREMATURITY (ROP)

Get alerted when new RETINOPATHY OF PREMATURITY (ROP) trials appear

New hope for tiniest babies: experimental drug aims to prevent devastating lung disease